Publications by authors named "Tohru Hashida"

Claim this Profile
E
Effect of Diabetes on Outcomes in Patients With Incurable/Unresectable and Advanced/Recurrent Colorectal Cancer Receiving mFOLFOX6.
Mai Ikemura, Masaki Hirabatake, Megumi Aburaya, Hiroaki Ikesue, Hisateru Yasui, Tohru Hashida

Cancer Diagn Progn· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics.
Haruno Oku, Saki Yoshida, Takumi Hotta, Hirohito Muroi, Keizo Fukushima, Tohru Hashida

Curr Ther Res Clin Exp· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Temozolomide in a Patient With Glioblastoma Undergoing Hemodialysis: A Short Communication.
Fumiaki Tanaka, Kei Irie, Nobuyuki Fukui, Ryo Horii, Hirotoshi Imamura, Tohru Hashida

Ther Drug Monit· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma.
Kenta Yamaoka, Kei Irie, Nobuhiro Hiramoto, Masaki Hirabatake, Hiroaki Ikesue, Tohru Hashida

Invest New Drugs· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist-Urologist Collaborative Management for Patients with Renal Cell Carcinoma Receiving Pazopanib Monotherapy.
Masaki Hirabatake, Hiroaki Ikesue, Shintaro Yoshino, Mayu Morimoto, Toshinari Yamasaki, Tohru Hashida

Biol Pharm Bull· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and exposure-clinical outcome relationship of remdesivir major metabolite GS-441524 in patients with moderate and severe COVID-19.
Ryo Tamura, Kei Irie, Atsushi Nakagawa, Hirohito Muroi, Masaaki Eto, Tohru Hashida

CPT Pharmacometrics Syst Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung Cancer.
Makiko Tohi, Kei Irie, Tomoyuki Mizuno, Hiroyuki Okuyoshi, Masaki Hirabatake, Tohru Hashida

Ther Drug Monit· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database.
Shiori Hasegawa, Hiroaki Ikesue, Riko Satake, Misaki Inoue, Yu Yoshida, Tohru Hashida

Drugs Real World Outcomes· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database.
Misaki Inoue, Kiyoka Matsumoto, Mizuki Tanaka, Yu Yoshida, Riko Satake, Tohru Hashida

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the safety and efficiency of robotic dispensing systems.
Tomoki Takase, Norio Masumoto, Naoki Shibatani, Yusaku Matsuoka, Fumiaki Tanaka, Tohru Hashida

J Pharm Health Care Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus pharmacokinetics and exposure-response relationship in Japanese patients with advanced breast cancer.
Masaki Hirabatake, Tomoyuki Mizuno, Hironori Kato, Tohru Hashida

Front Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors of proteinuria and potentially protective effect of renin-angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib.
Hiroaki Ikesue, Kenta Yamaoka, Ayako Matsumoto, Masaki Hirabatake, Nobuyuki Muroi, Tohru Hashida

Cancer Chemother Pharmacol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between 25-hydroxyvitamin D levels and COVID-19 severity.
Tomoki Takase, Naoko Tsugawa, Takayuki Sugiyama, Hiroaki Ikesue, Masaaki Eto, Tohru Hashida

Clin Nutr ESPEN· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide.
Masaki Hirabatake, Hiroaki Ikesue, Yuna Iwama, Kei Irie, Shintaro Yoshino, Tohru Hashida

Front Pharmacol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors of Proteinuria in Patients with Hepatocellular Carcinoma Receiving Lenvatinib.
Hiroaki Ikesue, Haruna Yamamoto, Masaki Hirabatake, Tohru Hashida, Hobyung Chung

Biol Pharm Bull· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score-matched analysis.
Hiroaki Ikesue, Kohei Doi, Mayu Morimoto, Masaki Hirabatake, Nobuyuki Muroi, Tohru Hashida

Support Care Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of favipiravir in patients with COVID-19.
Kei Irie, Atsushi Nakagawa, Hirotoshi Fujita, Ryo Tamura, Masaaki Eto, Tohru Hashida

CPT Pharmacometrics Syst Pharmacol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Consideration on Expiration Days Setting for the Introduction of Drug Vial Optimization].
Koji Hama, Masaki Hirabatake, Hiroaki Ikesue, Nobuyuki Muroi, Tohru Hashida

Gan To Kagaku Ryoho· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases.
Hiroaki Ikesue, Moe Mouri, Hideaki Tomita, Masaki Hirabatake, Mai Ikemura, Tohru Hashida

Support Care Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study.
Kanae Yamashita, Yoshimitsu Shimomura, Hiroaki Ikesue, Nobuyuki Muroi, Akihiro Yoshimoto, Tohru Hashida

BMC Infect Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of Drug-Induced Gastrointestinal Obstruction and Perforation Using the Japanese Adverse Drug Event Report Database.
Riko Satake, Kiyoka Matsumoto, Mizuki Tanaka, Ririka Mukai, Kazuyo Shimada, Tohru Hashida

Front Pharmacol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases.
Hiroaki Ikesue, Kohei Doi, Mayu Morimoto, Masaki Hirabatake, Nobuyuki Muroi, Tohru Hashida

Cancer Chemother Pharmacol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting.
Fumiaki Tanaka, Naoki Shibatani, Kazumi Fujita, Hiroaki Ikesue, Satoru Yoshimizu, Tohru Hashida

J Pharm Health Care Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database.
Misaki Inoue, Kiyoka Matsumoto, Mizuki Tanaka, Yu Yoshida, Riko Satake, Tohru Hashida

Sci Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma concentration of amitriptyline and metabolites after resuscitation from cardiopulmonary arrest following an overdose: A case report.
Motozumi Ando, Ryo Tamura, Shinji Nakasako, Satsuki Takimoto, Koichi Ariyoshi, Tohru Hashida

Clin Case Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis